The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1195-1196, December 2009

Pharmacogenetics of β2-agonists in children

  • Michael Kabesch, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Michael Kabesch, MD, Center for Pediatrics, Clinic for Pediatric Pneumology and Neonatology, Hannover Medical School, Carl-Neuberg-Str 1, D-30625 Hannover, Germany.

Center for Pediatrics, Clinic for Pediatric Pneumology and Neonatology, Hannover Medical School, Hannover, Germany

Received 15 September 2009; accepted 15 September 2009. published online 12 November 2009.

Key words: β-Agonists, children, asthma

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Disclosure of potential conflict of interest: M. Kabesch has received reimbursement for lectures from or served on advisory boards for Roxall, Glaxo Wellcome, Novartis, Sanofi Aventis, and Allergopharma, and has received research support from the Deutsche Forschungsgemeinschaft, the Federal Ministry of Education and Research (BMBF), and the European Union.

PII: S0091-6749(09)01412-2

doi:10.1016/j.jaci.2009.09.023

Refers to article:

  • Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol , 05 October 2009

    Kaninika Basu, Colin N.A. Palmer, Roger Tavendale, Brian J. Lipworth, Somnath Mukhopadhyay
    The Journal of Allergy and Clinical Immunology December 2009 (Vol. 124, Issue 6, Pages 1188-1194.e3)

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1195-1196, December 2009

Article Tools